The Director of Clinical Operations is responsible for leadership of all clinical development deliverables to support Cybin’s program to advance psychedelic therapeutics. The role involves integrating strategy, design, feasibility, and operational planning to produce business-focused clinical drug development programs that align with the company strategy. Essential Functions Responsible for the operational strategy and overall execution of Phase 1, Phase 2, and Phase 3 clinical programs with psychedelic therapeutics, which includes scope, quality, budget, time, resources, […]
About the company One in ten people today live with a mental health disorder. At Maya, we know that psychedelic medicine has the power to shift the paradigm of mental healthcare on a global scale. However, the pioneers in psychedelic medicine don’t have an easy way to to demonstrate the clinical benefits of their work. Maya is a software platform designed to help psychedelic practitioners manage, measure, and illustrate health outcomes, so they can optimize […]
Role Lead design at Mindbloom to create life-changing psychedelic therapy experiences and build a household brand Convert quantitative and qualitative client data, ideas from our team of experts, and your creative vision into fully executable designs Deeply understand our clients in order to design experiences that deliver clinical outcomes and client awe Intentionally craft every stage of the client journey including physical products, mobile consumer software, therapeutic content, human care delivery, and more Build and […]
Role Lead operations at Mindbloom in order to meet soaring demand by rapidly expanding our complex supply chain while staying in compliance with state and federal regulations governing telemedicine Scale Mindbloom’s clinician, guide, and support partners from 20 to 200 over the next 24 months Own gross margins, capacity, fulfillment, scheduling, and Cx kpis by running a rigorous, data-driven organization Build and lead a team of experts who care personally and embody Mindbloom’s Culture of […]
Background Fireside Project is a non-profit organization that will operate the Psychedelic Peer Support Line. When the support line goes live on April 14, 2021, it will be the first ever peer support line that’s specifically aimed at helping people navigate psychedelic experiences. To learn more about it, please check out this page, our Medium article, and maybe even our public panel. At Fireside Project, we are deeply passionate about the psychedelic movement, and we are all working to […]
Hive Australia is searching for an entrepreneurial CEO with experience in healthcare, hospitality, wellness and startups who is passionate about the psychedelics renaissance and wants to work in a global, VC backed company. Hive Hive Australia (Byron Bay) is an Australian branch of Hive – a network of state of the art mental health centers using psychedelics assisted therapies. Hive is backed by the Conscious Fund – the most prominent VC fund investing into psychedelics […]
We are looking for senior researchers and medical practitioners involved with dementia, Alzheimer’s and palliative care. Working with a group of specialist investors, advocates and corporate professionals we are creating a new approach to the treatment of these issues. We are seeking a broad group including scientific researchers, doctors, patient advocates and drug developers. Candidates will need world class backgrounds, extensive experience and recognised credentials as well as a very strong interest in the psychedelic […]
We are seeking a CEO for a groundbreaking new project currently at the startup phase. Working with scientists, medical professionals and financiers, we need a strong, entrepreneurial CEO to create a new initiative from existing frameworks. Ideally you will have good psychedelic medicine credentials, and have long standing experience through working in pharmaceuticals, biosciences or drug development. You will also have significant C level experience of Canadian or US public companies. Please note, this is […]
About MAPS Public Benefit Corporation (MAPS PBC): MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. Founded in 2014, MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS) a 501(c)(3) nonprofit. More information about the organization is available at http://www.mapspublicbenefit.com/ MAPS PBC is committed to the evolution of psychedelic healing modalities. We […]
About the Multidisciplinary Association for Psychedelic Studies (MAPS) MAPS is a 30-year old non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Emerging research indicates that psychedelic therapy has the potential to be a breakthrough approach in treating PTSD, depression, addiction, and other medical conditions. This shift has the potential to unlock previously unavailable resources for the investigation of psychedelic-assisted […]
Under the direction of the General Counsel, the Legal Counsel (Corporate) is responsible for a broad range of legal services and regulatory matters. Roles and responsibilities Responsibilities include (but are not limited to): SEC and Nasdaq Compliance Assist with annual stockholder meeting process Assist with the preparation and review of Annual Report and Quarterly and Periodic Filings, supplemental information and investor presentations Review internal reports, presentations and other materials for securities law compliance Oversee securities […]
Third Wave educates the public on the importance of responsible and intentional psychedelic use. Our vision is to help co-create a global movement that embraces psychedelic use as a way to heal ourselves and our world. We do that by sharing trusted, research-based content that helps people feel safe, supported, and empowered as they follow their paths towards personal transformation. Currently, we reach over 300K people per month and have been featured in the BBC, […]
About Third Wave Third Wave educates the public on the importance of responsible and intentional psychedelic use. Our mission is to facilitate the world’s adoption of psychedelics as useful tools for healing and transformation. We do this through well-researched online content that is widely accessible and well-branded. Currently, we reach over 300K people per month, and have been featured in the BBC, Forbes, and the New York Times. With the rapid growth of interest in […]
Position Summary We urgently need psychiatric support in the MAPS sponsored MDMA-assisted psychotherapy study for severe PTSD. We are one of the 14 sitesworldwide involved in this Phase III study of MDMA assistedpsychotherapy for severe PTSD. We are a large multi-disciplinaryintegrative mental health clinic in fort Collins, Colorado. Join two otherpsychiatrists who work alongside three naturopaths, psychotherapists,biofeedback practitioners, and advanced practice nurses. We currentlyprovide ketamine-assisted psychotherapy, IV nutrition, neurofeedback,and integrative psychiatric care in a collaborative […]
As the psychedelic renaissance gains momentum, the demand for high-quality financial reports detailing this space is greater than ever. Microdose and The Conscious Fund are excited to announce our upcoming investment grade intelligence guide to the psychedelic sector–and we need your help! We are looking to bring a Lead Editor on board to assist us in the completion of this project. The report has already been drafted by more than a dozen expert contributors and […]
The Medical Director, reporting into the Chief Medical Officer, will join our Clinical Science team in London. We are looking for a highly motivated and experienced physician to join our Clinical Science team in London as a Medical Director. This role will report into the Chief Medical Officer. Responsibilities include (but are not limited to): Being actively involved in collaborative efforts between clinical trial sites and Clinical Operations to ensure the high-quality execution of all […]
The Regulatory Affairs Lead, reporting into the Head of R&D, will take primary responsibility for the development and execution of our regulatory strategy. The role will involve managing all regulatory aspects of company products, information and activities, with particular emphasis on clinical and nonclinical development activities, and pharmacovigilance. Responsibilities include (but are not limited to): Acting as the point of contact for all interactions with Competent Authorities regarding the development of COMPASS Pathways products Ensure […]
This critical role will provide clinical and scientific leadership to advance the clinical development programme. The role will report in to the Chief Development Officer. The successful candidate must thrive working in a fast-paced, innovative environment while remaining flexible, resourceful and efficient. The ability to analyse complex issues developing relevant and realistic plans, programmes and recommendations are critical to success. The role will be a fundamental addition to the management team bringing significant innovative drug […]
ATAI is a Berlin, New York, and London based biotech company builder leveraging a decentralized, data-driven platform model with the aim of ultimately healing mental health disorders. We are dedicated to bringing innovation to mental healthcare, a field that has seen little progress since the development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the 1980s and 1990s, respectively. Our portfolio companies are developing innovative solutions in mental healthcare, including COMPASS Pathways […]
ATAI is a Berlin, New York, and London based biotech company builder leveraging a decentralized, data-driven platform model with the aim of ultimately healing mental health disorders. We are dedicated to bringing innovation to mental healthcare, a field that has seen little progress since the development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the 1980s and 1990s, respectively. Our portfolio companies are developing innovative solutions in mental healthcare, including COMPASS Pathways […]